How CAR T Cell Therapy Is Changing Lives

By rahmat hidayat

Friday, March 28, 2025

This advertisement is sent to you by your friends at Reader's Digest. Not actual patients  Understanding Multiple Myeloma: Multiple myeloma is an incurable blood cancer that originates in plasma cells in the bone marrow. Although the treatment landscape has improved, patients with this disease can exhibit both remission and relapse of the cancer, leaving patients searching for new options. How CAR T Cell Therapy May Help: Chimeric antigen receptor (CAR) T cell therapy is a personalized treatment option in which a patient's own T cells (a type of white blood cells) are genetically "reprogrammed" to recognize and fight cancer cells in the blood. After years of treatments, three patients living with multiple myeloma remained encouraged for the next step in their journeys with this therapy. Is CAR T Cell Therapy Right for You? If you or a loved one is facing relapsed or refractory multiple myeloma, talk to your doctor to see if CAR T cell therapy may be an option. LEARN MORE ABOUT THIS OPTION © 2025 Bristol Myers Squibb. All rights reserved. 01/25. HE-US-2400977.  Gift or subscribe to Reader's Digest! Subscribe Now > You are subscribed to this email as rh3252705.adda@blogger.com To unsubscribe or update your Email Preferences, click here. View our privacy policy. Trusted Media Brands, Inc. 1610 N. 2nd St., Suite 102 Milwaukee, WI 53212 Copyright © 2025 Trusted Media Brands. All rights reserved.

Share :

Facebook Twitter Google+ Lintasme